Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics

Bioinformatics

Volumn 28, Issue 16, 2012, Pages 2169-2175

  Hoehndorf, Robert ^a   Dumontier, Michel ^b   Gkoutos, Georgios V ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CARLETON UNIVERSITY   (Canada)

^c ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER PROGRAM; FACTUAL DATABASE; HUMAN; INFORMATION RETRIEVAL; KNOWLEDGE BASE; LINGUISTICS; METHODOLOGY; PHARMACOGENETICS; SYSTEM ANALYSIS;

DATABASES, FACTUAL; HUMANS; INFORMATION STORAGE AND RETRIEVAL; KNOWLEDGE BASES; PHARMACOGENETICS; SOFTWARE; SYSTEMS INTEGRATION; VOCABULARY, CONTROLLED;

EID: 84865171141     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/bts350     Document Type: Article

References (41)

1. Arts, E.J. et al. (1998) 3 -azido-3 -deoxythymidine (azt) mediates cross-resistance to nucleoside analogs in the case of azt-resistant human immunodeficiency virus type 1 variants. J. Virol., 72, 4858-4865.
2. Ashburner, M. et al. (2000) Gene ontology: tool for the unification of biology. Nat. Genet., 25.
3. Bard, J. et al. (2005) An ontology for cell types. Genome Biol., 6.
4. Bhatt, D.L. and Topol, E.J. (2003) Scientific and therapeutic advances in antiplatelet therapy. Nat. Rev. Drug Discov., 2, 15-28.
5. Bodenreider, O. (2004) The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res., 32.
6. Chen, L. et al. (2012) Integrative network analysis to identify aberrant pathway networks in ovarian cancer. Pacific Symp. Biocomput., 17, 31-42.
7. Chrisholm, R. et al. (2011) Disease ontology.
8. Coulet, A. et al. (2011) Integration and publication of heterogeneous text-mined relationships on the semantic web. J. Biomed. Semant., 2(Suppl. 2), S10+.
9. Davis, A.P. et al. (2010) The comparative toxicogenomics database: update 2011.
10. Nucleic Acids Res. Degtyarenko, K. et al. (2007) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res.
11. Demir, E. et al. (2010) The BioPAX community standard for pathway data sharing. Nat. Biotechnol., 28, 935-942.
12. Frissen, P.H. et al. (1994) Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis., 169, 1351-1355.
13. Gkoutos, G.V. et al. (2005) Using ontologies to describe mouse phenotypes. Genome Biol., 6.
14. Herbert, J.M. et al. (1993) Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler. Thromb., 13, 1171-1179.
15. Hoehndorf, R. et al. (2011a) A common layer of interoperability for biomedical ontologies based on OWL EL. Bioinformatics, 27, 1001-1008.
16. Hoehndorf, R. et al. (2011b) Integrating systems biology models and biomedical ontologies. BMC Sys. Biol., 5, 124+.
17. Hoehndorf, R. et al. (2011c) Interoperability between biomedical ontologies through relation expansion, upper-level ontologies and automatic reasoning. PLOS one, 6, e22006.
18. Hoehndorf, R. et al. (2011d) Phenomenet: a whole-phenome approach to disease gene discovery. Nucleic Acids Res., 39, e119.
19. Horridge, M. et al. (2007) Igniting the OWL 1.1 touch paper: The OWL API. In Proceedings of OWLED 2007: Third International Workshop on OWL Experiences and Directions.
20. Horrocks, I. (2007) OBO flat file format syntax and semantics and mapping to OWL Web Ontology Language. Technical report, University of Manchester. http://www.cs.man.ac.uk/horrocks/obo/.
21. International Warfarin Pharmacogenetics Consortium et al. (2009) Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med., 360, 753-764.
22. Kazakov, Y. et al. (2011) Unchain my EL reasoner. In Proceedings of the 23rd International Workshop on Description Logics (DL'10), CEUR Workshop Proceedings. CEUR-WS.org.
23. Knox, C. et al. (2010) Drugbank 3.0: a comprehensive resource for omics research on drugs. Nucleic Acids Res.
24. LePendu, P. et al. (2011) Enabling enrichment analysis with the human disease ontology. J. Biomed. Inform. In press.
25. Lewis, W. et al. (2001) Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic aids mice. Lab. Invest., 81, 1527-1536.
26. Martin, C.A. et al. (2008) Caffeine use: association with nicotine use, aggression, and other psychopathology in psychiatric and pediatric outpatient adolescents. ScientificWorldJournal, 8, 512-516.
27. Max, B. and Sherer, R. (2000) Management of the adverse effects of antiretroviral therapy and medication adherence. Clin. Infect. Dis., 30(Suppl. 2), S96-116.
28. Millar, J.K. et al. (2005) DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science, 310, 1187-1191.
29. Miller, G.C. and Britt, H. (1995) A new drug classification for computer systems: the atc extension code. Inter. J. Bio-Med. Comput., 40, 121-124. (Asia Pacific Association of Medical Informatics (APAMI)).
30. Motik, B. et al. (2009) Owl 2 web ontology language: Profiles. Recommendation, World Wide Web Consortium (W3C).
31. Osborne, J. et al. (2009a) Annotating the human genome with disease ontology. BMC Genomics, 10(Suppl. 1), S6+.
32. Osborne, J. et al. (2009b) Annotating the human genome with disease ontology. BMC Genomics, 10(Suppl. 1), S6+.
33. Prufer, K. et al. (2007) Func: a package for detecting significant associations between gene sets and ontological annotations. BMC Bioinformatics, 8, 41+.
34. Robinson, P.N. et al. (2008) The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am. J. Hum. Genet., 83, 610-615.
35. Rosse, C. and Mejino, J.L.V. (2003) A reference ontology for biomedical informatics: the Foundational Model of Anatomy. J. Biomed. Inform., 36, 478-500.
36. Savi, P. et al. (1994) The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome p450-1a. Thromb. Haemost., 72, 313-317.
37. Sim, S.C. et al. (2011) Databases in the area of pharmacogenetics. Hum. Mutat.
38. Subramanian, A. et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Nat. Acad. Sci. USA, 102, 15545-15550.
39. Thorn, C.F. et al. (2010) Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics, 11, 501-505.
40. Wang, J. et al. (2012) Identification of aberrant pathways and network activities from high-throughput data. Brief. Bioinform.
41. Yang, L.H. and Fareed, J. (1997) Vasomodulatory action of clopidogrel and ticlopidine. Thromb. Res., 86, 479-491.